Our Vision
at the peri-infarct zone 3 days post myocardial infarction The potential involvement of the TRPV2 Ca2+channel in cardiac pathology, oncology and cardiac-oncology. A TRPV2 blocking agent is being developed in collaboration with the BLAVATNIK center for drug discovery. are highly involved in mediating cardiac pathology and progression to reno-cardiac syndrome following cardiac injury Highlighted Publications
Translational-oriented research of cardiac pathology Our Team
Research
